{
    "nctId": "NCT02450357",
    "briefTitle": "The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment",
    "officialTitle": "The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment",
    "overallStatus": "COMPLETED",
    "conditions": "Neoplastic Cells, Circulating",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "The number of Circulating Tumor Cells (CTCs)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age:18-75\n2. Karnofsky performance status \\>60\n3. Diagnosis of breast cancer based on histology or the current accepted radiological measures.\n4. Classification tumor,nodes,metastasis-classification(TNM) stage: \u2161,\u2162,\u2163\n5. Will receive cryosurgery and/or DC-CIK treatment\n6. Life expectancy: Greater than 3 months\n7. Patients' routine blood test, liver function and kidney function have no obvious abnormalities\n8. Ability to understand the study protocol and a willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n1. Patients with other primary tumor except lung cancer\n2. History of coagulation disorders or anemia",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}